PR Newswire
BRAINTREE, Mass., Nov. 7, 2017
BRAINTREE, Mass., Nov. 7, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that second quarter and first half fiscal 2018 financial results are available on its Investor relations website.
The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.
Direct link to Earnings Release 2Q and 1H FY18:
Direct link to Results Tables 2Q and 1H FY18 That Will Be Referenced on Webcast:
As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on November 7, 2017. A live webcast of the call can be accessed on Haemonetics' investor relations website.
Direct link to Conference Call Webcast: https://edge.media-server.com/m6/p/cuu23zsw.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
CONTACT:
Gerry Gould, VP-Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com
View original content with multimedia:http://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-and-1st-half-fiscal-2018-earnings-release-available-on-investor-relations-website-300550189.html
SOURCE Haemonetics Corporation
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.